AP1730A - Multiple target test useful for pre-donation screening of blood. - Google Patents

Multiple target test useful for pre-donation screening of blood.

Info

Publication number
AP1730A
AP1730A APAP/P/2003/002815A AP2003002815A AP1730A AP 1730 A AP1730 A AP 1730A AP 2003002815 A AP2003002815 A AP 2003002815A AP 1730 A AP1730 A AP 1730A
Authority
AP
ARIPO
Prior art keywords
blood
tests
targets
donation
multiple target
Prior art date
Application number
APAP/P/2003/002815A
Other versions
AP2003002815A0 (en
Inventor
Lee Helen
Jean-Pierre Allain
Original Assignee
Lee Helen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lee Helen filed Critical Lee Helen
Publication of AP2003002815A0 publication Critical patent/AP2003002815A0/en
Application granted granted Critical
Publication of AP1730A publication Critical patent/AP1730A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Tests for establishing whether any of a plurality of different targets are present in a sample solution are described. If one or more of the targets are detected a positive result is obtained, but the different targets are not differentiated by the test, so there is no indication which targets have been detected. Such tests are useful for pre-donation screening of blood at public blood donation sessions to test whether the blood is safe for transfusion. The tests allow infected blood lo be identified, but preserve the confidentiality of the reason for refusal of infected blood. This avoids the distress caused by public diagnosis of infection by diseases with which there is a social stigma attached, such as HIV. The tests are particularly suited for use in developing countries to screen for HIV. HBV, and HCV infection. Dipsticks and kits for performing the tests are also described.
APAP/P/2003/002815A 2000-12-21 2001-12-21 Multiple target test useful for pre-donation screening of blood. AP1730A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0031391.6A GB0031391D0 (en) 2000-12-21 2000-12-21 Pre-donation testing
PCT/GB2001/005792 WO2002050544A1 (en) 2000-12-21 2001-12-21 Multiple target test useful for pre-donation screening of blood

Publications (2)

Publication Number Publication Date
AP2003002815A0 AP2003002815A0 (en) 2003-06-30
AP1730A true AP1730A (en) 2007-03-30

Family

ID=9905695

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2003/002815A AP1730A (en) 2000-12-21 2001-12-21 Multiple target test useful for pre-donation screening of blood.

Country Status (6)

Country Link
CN (1) CN1486425A (en)
AP (1) AP1730A (en)
AU (1) AU2002216285A1 (en)
GB (1) GB0031391D0 (en)
OA (1) OA12487A (en)
WO (1) WO2002050544A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE544519T1 (en) * 2004-12-13 2012-02-15 Bayer Healthcare Llc INDEPENDENT TEST SENSOR
CN101246168B (en) * 2008-01-29 2013-07-24 马义才 Portable venereal disease all-in-one fast joint inspection device
WO2021134307A1 (en) * 2019-12-30 2021-07-08 深圳迈瑞生物医疗电子股份有限公司 Kit for testing infectious diseases, method, and immunoassay analyzer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023299A1 (en) * 1993-03-31 1994-10-13 Quidel Corporation Multiple assay device
WO1997034148A1 (en) * 1996-03-14 1997-09-18 Spectral Diagnostics, Inc. Immunoassay device
US5770460A (en) * 1991-01-11 1998-06-23 Quidel Corporation One-step lateral flow nonbibulous assay

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141850A (en) * 1990-02-07 1992-08-25 Hygeia Sciences, Inc. Porous strip form assay device method
EP0705426A4 (en) * 1993-06-09 1998-07-08 Quidel Corp Antigen-specific one-step assays
WO1995027081A1 (en) * 1994-03-31 1995-10-12 E.I. Du Pont De Nemours And Company A method for detection of nucleic acid fragments
JPH10511460A (en) * 1994-12-22 1998-11-04 アボツト・ラボラトリーズ Time difference detection method for multiple analytes in test sample
US5741662A (en) * 1995-12-18 1998-04-21 Quidel Corporation Direct stain specific binding assays for microorganisms
WO1998036278A1 (en) * 1997-02-15 1998-08-20 Beth Israel Deaconess Medical Center, Inc. Multiple-site antibody capture immunoassays and kits

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770460A (en) * 1991-01-11 1998-06-23 Quidel Corporation One-step lateral flow nonbibulous assay
WO1994023299A1 (en) * 1993-03-31 1994-10-13 Quidel Corporation Multiple assay device
WO1997034148A1 (en) * 1996-03-14 1997-09-18 Spectral Diagnostics, Inc. Immunoassay device

Also Published As

Publication number Publication date
WO2002050544A1 (en) 2002-06-27
AP2003002815A0 (en) 2003-06-30
AU2002216285A1 (en) 2002-07-01
GB0031391D0 (en) 2001-02-07
OA12487A (en) 2006-05-24
CN1486425A (en) 2004-03-31

Similar Documents

Publication Publication Date Title
Pennap et al. Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria
Das et al. Seroprevalence of Hepatitis B, Hepatitis C, and human immunodeficiency virus among healthy voluntary first-time blood donors in Kolkata
Choudhury et al. Transfusion transmitted diseases
Shrestha et al. Hepatitis E virus RNA in Australian blood donations
El-Shishtawy et al. Occult hepatitis C virus infection in hemodialysis patients; single center study
Mbulaiteye et al. Pleural and peritoneal lymphoma among people with AIDS in the United States
Moreira et al. Hepatitis C and hemodialysis: a review
Cilliers et al. Human immunodeficiency virus in cadavers: A review
AP1730A (en) Multiple target test useful for pre-donation screening of blood.
Ohhashi et al. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system
Forbi et al. Intra‐host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire
Sultana et al. Hepatitis C virus genotypes in injecting drug users from Romania
Hussein Evaluation of infectious disease markers in multitransfused Egyptian children with thalassemia
Alvarez-Muñoz et al. Hepatitis C virus RNA (HCV-RNA) in blood donors and family members seropositive for anti-HCV antibodies
Puro et al. Hepatitis C virus infection in healthcare workers
Radhiga et al. Patterns of transfusion transmitted infection in past ten years among voluntary blood donors in Chennai-a cross sectional study
Shah et al. Prevalence of HIV-I/II, HCV, HBsAg& Syphilis in Blood Donors Of Western Region In India.
Chaurasia et al. Pattern of transfusion transmitted infections in blood donors around Bhopal-a 5 years retrospective study
Panhotra et al. Visual detection of multiple viral amplicons by dipstick assay: its application in screening of blood donors a welcome tool for the limited resource settings
Datta et al. Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients
Gańczak et al. Rationale against preoperative screening for HIV in Polish hospitals: a prevalence study of anti-HIV in contrast to anti-hepatitis C virus and hepatitis B surface antigen
Brojer Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Poland
Chhetri Sero-prevalence of transfusion transmitted infections among blood donors at CRRH, Gelephu, Bhutan
Alom et al. Sero-prevalence of transfusion transmissible infections among voluntary blood donors of Khulna Medical College Hospital
Alidjinou et al. Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors